Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Techdow Pharma Netherlands is the European commercial subsidiary of Shenzhen Hepalink Pharmaceutical Group, one of the world's largest producers of heparin. The company specializes in the distribution and marketing of Inhixa, a biosimilar enoxaparin sodium used for the prevention and treatment of deep vein thrombosis and pulmonary embolism. Based in Hoofddorp, the Netherlands office serves as a strategic hub for regulatory affairs, medical information, and sales operations within the Benelux region. Techdow leverages its parent company's vertically integrated supply chain to ensure the high-quality production and reliable delivery of anticoagulant therapies to healthcare providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Techdow Pharma Netherlands.